These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9683783)

  • 1. Telomerase activity and telomere lengths in various cell lines: changes of telomerase activity can be another method for chemosensitivity evaluation.
    Park KH; Rha SY; Kim CH; Kim TS; Yoo NC; Kim JH; Roh JK; Noh SH; Min JS; Lee KS; Kim BS; Chung HC
    Int J Oncol; 1998 Sep; 13(3):489-95. PubMed ID: 9683783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes of telomerase and telomere lengths in paired normal and cancer tissues of breast.
    Rha SY; Park KH; Kim TS; Yoo NC; Yang WI; Roh JK; Min JS; Lee KS; Kim BS; Choi JH; Lim HY; Chung HC
    Int J Oncol; 1999 Oct; 15(4):839-45. PubMed ID: 10493971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel telomere elongation in an adriamycin-resistant stomach cancer cell line with decreased telomerase activity.
    Kim JH; Lee GE; Kim JC; Lee JH; Chung IK
    Mol Cells; 2002 Apr; 13(2):228-36. PubMed ID: 12018844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of telomere and telomerase interactive agents on human tumor and normal cell lines.
    Rha SY; Izbicka E; Lawrence R; Davidson K; Sun D; Moyer MP; Roodman GD; Hurley L; Von Hoff D
    Clin Cancer Res; 2000 Mar; 6(3):987-93. PubMed ID: 10741725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
    Engelhardt M; Drullinsky P; Guillem J; Moore MA
    Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomere length, telomerase activity and telomerase RNA expression in human esophageal cancer cells: correlation with cell proliferation, differentiation and chemosensitivity to anticancer drugs.
    Asai A; Kiyozuka Y; Yoshida R; Fujii T; Hioki K; Tsubura A
    Anticancer Res; 1998; 18(3A):1465-72. PubMed ID: 9673357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical usefulness of telomerase activation and telomere length in head and neck cancer.
    Patel MM; Parekh LJ; Jha FP; Sainger RN; Patel JB; Patel DD; Shah PM; Patel PS
    Head Neck; 2002 Dec; 24(12):1060-7. PubMed ID: 12454944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomerase activity and telomere length in human ovarian cancer and melanoma cell lines: correlation with sensitivity to DNA damaging agents.
    Villa R; Folini M; Perego P; Supino R; Setti E; Daidone MG; Zunino F; Zaffaroni N
    Int J Oncol; 2000 May; 16(5):995-1002. PubMed ID: 10762636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of chemosensitivity to anticancer drugs and telomere length, telomerase activity and telomerase RNA expression in human ovarian cancer cells.
    Kiyozuka Y; Yamamoto D; Yang J; Uemura Y; Senzaki H; Adachi S; Tsubura A
    Anticancer Res; 2000; 20(1A):203-12. PubMed ID: 10769656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of telomere and telomerase in human primary gastric carcinoma].
    Zhang F; Zhang X; Fan D
    Zhonghua Bing Li Xue Za Zhi; 1998 Dec; 27(6):429-32. PubMed ID: 11244953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomere length and telomerase activity in carcinogenesis of the stomach.
    Maruyama Y; Hanai H; Fujita M; Kaneko E
    Jpn J Clin Oncol; 1997 Aug; 27(4):216-20. PubMed ID: 9379506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic determination of telomerase activity and telomerase length during the progression of human breast cancer in cell culture models.
    Imam SA; Kim MS; Anker L; Datar RH; Law RE; Taylor CR
    Anticancer Res; 1997; 17(6D):4435-41. PubMed ID: 9494546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A human breast cancer model for the study of telomerase inhibitors based on a new biotinylated-primer extension assay.
    Raymond E; Sun D; Izbicka E; Mangold G; Silvas E; Windle B; Sharma S; Soda H; Laurence R; Davidson K; Von Hoff DD
    Br J Cancer; 1999 Jul; 80(9):1332-41. PubMed ID: 10424733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of telomeres and telomerase.
    Herbert BS; Shay JW; Wright WE
    Curr Protoc Cell Biol; 2003 Nov; Chapter 18():Unit 18.6. PubMed ID: 18228424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Equine telomeres and telomerase in cellular immortalisation and ageing.
    Argyle D; Ellsmore V; Gault EA; Munro AF; Nasir L
    Mech Ageing Dev; 2003 Jun; 124(6):759-64. PubMed ID: 12782419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression for suppressors of telomerase activity (telomeric-repeat binding factors) in breast cancer.
    Saito K; Yagihashi A; Nasu S; Izawa Y; Nakamura M; Kobayashi D; Tsuji N; Watanabe N
    Jpn J Cancer Res; 2002 Mar; 93(3):253-8. PubMed ID: 11927006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma.
    Engelhardt M; Albanell J; Drullinsky P; Han W; Guillem J; Scher HI; Reuter V; Moore MA
    Clin Cancer Res; 1997 Oct; 3(10):1849-57. PubMed ID: 9815573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effect of telomere-mimic phosphorothioate oligodeoxy nucleotides (S-ODNS) on human tumor cell lines.
    Saeki T; Takashima S; Tachibana M; Koga M; Hiyama E; Salomon DS; Holland JF; Ohnuma T
    Oncology; 1999 Oct; 57 Suppl 2():27-36. PubMed ID: 10545800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of retinoblastoma in the absence of telomerase activity.
    Gupta J; Han LP; Wang P; Gallie BL; Bacchetti S
    J Natl Cancer Inst; 1996 Aug; 88(16):1152-7. PubMed ID: 8757195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic induction of senescence with intermittent AZT treatment accelerates both apoptosis and telomere loss.
    Ji HJ; Rha SY; Jeung HC; Yang SH; An SW; Chung HC
    Breast Cancer Res Treat; 2005 Oct; 93(3):227-36. PubMed ID: 16132531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.